RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2

RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2

RALYL is a liver progenitor cell-specific gene but its role in hepatocellular carcinoma (HCC) remains unknown. Here, the authors demonstrate that RALYL regulates HCC stemness through upregulation of TGF-β2 mRNA stability by decreasing N6-methyladenosine modification.

Bibliographic Details
Main Authors:	Xia Wang, Jin Wang, Yu-Man Tsui, Chaoran Shi, Ying Wang, Xin Zhang, Qian Yan, Miao Chen, Chen Jiang, Yun-Fei Yuan, Chun-Ming Wong, Ming Liu, Zeng-yu Feng, Honglin Chen, Irene Oi Lin Ng, Lingxi Jiang, Xin-Yuan Guan
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-03-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-021-21828-7

Similar Items

Exploring the role of RALYL in Alzheimer’s disease reserve by network-based approaches
by: Yixuan Zhang, et al.
Published: (2020-12-01)

PITX2C increases the stemness features of hepatocellular carcinoma cells by up-regulating key developmental factors in liver progenitor
by: Lingxi Jiang, et al.
Published: (2022-06-01)

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular CarcinomaSummary
by: Xueying Lyu, et al.
Published: (2022-01-01)

Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
by: Jian Wang, et al.
Published: (2011-01-01)

A circular RNA activated by TGFβ promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability
by: Ke Li, et al.
Published: (2023-10-01)

Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating CellsSummary
by: Hongyang Huang, et al.
Published: (2023-01-01)

Microbiota, Epithelium, Inflammation, and TGF-β Signaling: An Intricate Interaction in Oncogenesis
by: Xin Pang, et al.
Published: (2018-06-01)

TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization
by: Yinan Shen, et al.
Published: (2015-03-01)

Single laparoscopic hepatectomy for a 11-cm hepatocellular carcinoma
by: Yuan Cheng, et al.
Published: (2012-08-01)

Extracellular vesicles and cancer stemness in hepatocellular carcinoma – is there a link?
by: Lu Tian, et al.
Published: (2024-02-01)

PIAS3 promotes ferroptosis by regulating TXNIP via TGF-β signaling pathway in hepatocellular carcinoma
by: Wenfang Bao, et al.
Published: (2023-10-01)

TGF-β1 Promotes Hepatocellular Carcinoma Invasion and Metastasis via ERK Pathway-Mediated FGFR4 Expression
by: Jiawei Huang, et al.
Published: (2018-02-01)

Differential expression of TGF-β1 receptors ALK1/ALK5 in pterygium and normal conjunctiva tissues
by: Can Zhang*, et al.
Published: (2021-11-01)

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent MannerSummary
by: Charles Shing Kam, et al.
Published: (2023-01-01)

Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model
by: Xin-Yu Ge, et al.
Published: (2023-03-01)

Oncological prognosis and morbidity of hepatectomy in elderly patients with hepatocellular carcinoma: a propensity score matching and multicentre study
by: Chuan-Ming Wang, et al.
Published: (2023-10-01)

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
by: Yu-Shiuan Wang, et al.
Published: (2023-10-01)

HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro
by: Jie Zhao, et al.
Published: (2016-05-01)

Down‐regulation of TROP‐2 Predicts Poor Prognosis of Hepatocellular Carcinoma Patients
by: Sarah T. K. Sin, et al.
Published: (2018-11-01)

Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma
by: Mengzhen Han, et al.
Published: (2020-12-01)

Predicting Value of ALCAM as a Target Gene of microRNA-483-5p in Patients with Early Recurrence in Hepatocellular Carcinoma
by: Xin-Yuan Lu, et al.
Published: (2018-01-01)

TGF-β1-Mediated FDNCR1 Regulates Porcine Preadipocyte Differentiation via the TGF-β Signaling Pathway
by: Zhe Zhang, et al.
Published: (2020-08-01)

Autocrine EGF and TGF‐α promote primary and acquired resistance to ALK/c‐Met kinase inhibitors in non‐small‐cell lung cancer
by: Yueqin Wang, et al.
Published: (2023-02-01)

Over-Expression of Inhibitor of Differentiation 2 Attenuates Post-Infarct Cardiac Fibrosis Through Inhibition of TGF-β1/Smad3/HIF-1α/IL-11 Signaling Pathway
by: Lin Yin, et al.
Published: (2019-11-01)

PRR34-AS1 promotes exosome secretion of VEGF and TGF-β via recruiting DDX3X to stabilize Rab27a mRNA in hepatocellular carcinoma
by: Zhilei Zhang, et al.
Published: (2022-10-01)

High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity
by: Xiuli Jin, et al.
Published: (2022-04-01)

LINC00665 regulates hepatocellular carcinoma by modulating mRNA via the m6A enzyme
by: Lei Ming, et al.
Published: (2022-02-01)

Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma
by: Rui Peng, et al.
Published: (2019-03-01)

Up-regulation of TGF-β1 mRNA expression in peripheral blood mononuclear cells of patients with chronic fatigue syndrome
by: Hai-Ying Zhang, et al.
Published: (2011-11-01)

Retraction: TGF-β1 Regulation of Estrogen Production in Mature Rat Leydig Cells.
by: Man-Li Liu, et al.
Published: (2024-01-01)

Atypical magnetic resonance imaging features and differential diagnosis of hepatocellular carcinoma
by: Shuang-Yu Wang, et al.
Published: (2020-10-01)

miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial–mesenchymal transition
by: Yue Yu, et al.
Published: (2018-03-01)

BAG3 Suppresses Loading of Ago2 to IL6 mRNA in Pancreatic Ductal Adenocarcinoma
by: Chao Li, et al.
Published: (2019-04-01)

TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
by: Xiaoxin Mu, et al.
Published: (2013-01-01)

The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma
by: Man Wang, et al.
Published: (2020-09-01)

Clinical Characteristics of Hepatocellular Carcinoma in Elderly Patients
by: Tsang-En Wang, et al.
Published: (2013-06-01)

Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis.
by: Yu-Ling Chen, et al.
Published: (2013-01-01)

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
by: Chen Shen, et al.
Published: (2023-01-01)

Type III TGF-β Receptor Down-Regulation Promoted Tumor Progression via Complement Component C5a Induction in Hepatocellular Carcinoma
by: Oscar Wai Ho Yeung, et al.
Published: (2021-03-01)

MAEL Augments Cancer Stemness Properties and Resistance to Sorafenib in Hepatocellular Carcinoma through the PTGS2/AKT/STAT3 Axis
by: Chaoran Shi, et al.
Published: (2022-06-01)